Business Wire

Industry Voices Serious Concerns on Single Use Plastics Proposal at British Chamber of Commerce in Brussels Debate

Jaa

British Chamber of Commerce | EU & Belgium:

Just two days before a crucial Parliamentary vote, a debate on the workability of the EU Commission’s proposal to limit the impact of single use plastics on the marine environment has raised pressing concerns from industry and senior policy experts.

Amongst these concerns were the flaws of the impact assessment by the Commission, which neglected to estimate costs to industry of the proposals. The debate also heard that the far-reaching amendments proposed by the European Parliament, which will be voted on Wednesday 10 October, should be subject to a social and economic impact assessment based on real evidence and data.

Chairing the debate James Stevens, Partner at Rud Pedersen and Chair of the Energy, Transport and Chemicals Task Force at the British Chamber of Commerce pointed out: “The event was a great example of what the Chamber does best: bringing together institutional actors with representatives of wide range of interests from across its broad membership base to discuss a current legislative proposal. While for many in the institutions the adoption of the Commission’s proposal on single use plastics will be a political win just before the European elections, it was clear from the debate that much of the detail, and therefore the impact on industry, will not be clear for some time to come. It may well be another example of how the speed of the legislative process is often inversely proportionate to the quality of the final legislation.”

Representing the EU Commission, Hugo-Maria Schally, Head of Unit at the European Commission’s DG Environment, said that speed at which this proposal has been pushed reflected the urgency of the problem to clean up single use plastics from the marine environment. Yet according to industry representatives present, the proposal risked Member State fragmentation, meaning the EU would end up with 27 different ecodesign schemes from the 27 different Member States, and with no predictability for industry as to either the cost or effectiveness of the investment.

Speaking on the panel, Virginia Janssens, Managing Director of the European Organization for Packaging & the Environment (EuroPEN) highlighted the overlap with the Waste Framework Directive which already obliges Member States to tackle marine litter and provides a framework for establishing Extended Producer Responsibility schemes, under which producers are given a significant financial responsibility.

According to senior policy expert Vicky Marissen, Partner at EPPA, the principle of subsidiarity means Member States should have the opportunity to implement the Waste Directive first before implementing additional legislation.

Widely attended by British Chamber members from across various industries, the event concluded by emphasising that the key to success is not just political will, but legislation that offers legal certainty and regulatory coherence for business, in order to achieve the environmental ambitions of legislators, industry and other stakeholders.

Speakers at the event included:

  • Hugo-Maria Schally, Head of Unit for " Sustainable production, products and consumption " at the European Commission
  • Virginia Janssens, Managing Director for the European Organization for Packaging and the Environment | EUROPEN aisbl
  • Vicky Marissen, Partner, EPPA

About the British Chamber of Commerce | EU & Belgium

We are a not-for-profit serving our members by facilitating business in Belgium and engaging with the European Union and its decision making. The chamber has been serving the international business community here for over 100 years. Our members are small to large businesses from Britain and across the world - all with a stake in the success of Europe and its economy. They employ 1.2m people in the UK alone, with at least as many again in the rest of Europe. www.britishchamber.be

Contact information

For media queries
CHRISTOPHER MARTIN
EU and Brexit Events Officer
+32 26 13 28 (54)
euc-assistant@britishchamber.eu

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme